ELGX acquires TRIV for $9.10/sh in cash and stock—an 81% premium to today’s closing price: http://finance.yahoo.com/news/endologix-inc-trivascular-technologies-inc-200200285.html TRIV rose 55% in AH trading to $7.80, but remained well below the nominal buyout price of $9.10.